Eli Lilly Gets CDSCO Nod To Study Anti-diabetic Dulaglutide Dr. Divya Colin12 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Eli Lilly has got the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
Sanofi gets CDSCO panel nod to market Biphasic Insulin Aspart Injection Dr. Divya Colin8 Nov 2022 6:00 PM ISTNew Delhi: With a condition of conducting a phase IV study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Health Ministry forms panel to prepare National Drugs Database Dr. Nandita Mohan7 Nov 2022 5:25 PM ISTIn an efforts to ensure the quality and efficacy of medications and uniform administration of drug regulation, the Ministry of Health and Family...
Govt sets up committee to prepare National Drugs Database Susmita Roy6 Nov 2022 3:36 PM ISTNew Delhi: In an efforts to ensure the quality and efficacy of medications and uniform administration of drug regulation, the Ministry of Health and...
Johnson & Johnson Gets CDSCO Panel Okay To Study Anti-cancer Drug Lazertinib/Amivantamab Dr. Divya Colin4 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Johnson and Johnson has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Glenmark gets CDSCO Panel nod to manufacture,market Lobeglitazone, Metformin antidiabetic FDC Susmita Roy31 Oct 2022 6:00 PM ISTNew Delhi: Highlighting the clinical trial results that demonstrate the efficacy and safety of combination treatment of Lobeglitazone and Metformin in...
CDSCO panel approves Intas pharma to continue Tofacitinib Ointment 2% CT Study Dr. Divya Colin29 Oct 2022 5:15 PM ISTNew Delhi: Citing that drug maker, Intas Pharma should report in case of any Serious Adverse Events (SAEs) related to the Phase III clinical trial of...
IQVIA gets CDSCO panel okay to reopen trial recruitment in the country for Evobrutinib Dr. Divya Colin26 Oct 2022 1:30 PM ISTNew Delhi: Approving IQVIA proposal to amend Phase III Clinical Trail protocol of Bruton's tyrosine kinase (BTK) inhibitor Evobrutinib, the Subject...
Submit adequate justification: CDSCO Panel tells Synokem pharma about Phase III CT of Naftifine Cream Dr. Divya Colin26 Oct 2022 11:45 AM ISTNew Delhi: Regarding the ongoing Phase III Clinical trial with the drug Naftifine HCI Cream 2%w/w, the Subject Expert Committee (SEC) functional under...
Lupin Ranibizumab intravitreal injection gets CDSCO Panel nod for Phase IV study Dr. Divya Colin25 Oct 2022 10:45 AM ISTNew Delhi: Pharmaceuticals major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dr Reddys Labs bags CDSCO panel conditional nod to manufacture, market Nimesulide Granules Dr. Nandita Mohan22 Oct 2022 1:18 PM IST Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject Expert...
Health Bulletin 21/October/2022 Dr. Nandita Mohan21 Oct 2022 5:43 PM ISTHere are the top health stories for the day:MBBS Admission: Bombay HC orders medical re-examination of student with locomotor disabilityWhile...
